NCT00004550

Brief Summary

The purpose of this study is to better understand the long-term progress of people with obsessive-compulsive disorder (OCD) and related conditions such as anorexia nervosa, Tourette syndrome, and trichotillomania. This study involves the screening and follow-up of individuals with OCD and OCD-related disorders. Participants will be screened with a medical and psychiatric evaluation, questionnaires, and neurological testing. Participants will then have study visits every 4 to 12 weeks to undergo symptom and daily functioning evaluations, personality tests, blood and urine tests, memory tests, brain scans, and other clinical exams. Participants will be assessed with interviews and paper-and-pencil or computer-assisted tests. Participants may have the opportunity to participate in drug studies and to join a monthly OCD support group. At the end of the study, participants will be referred to community or private treatment centers.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2000

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 28, 2000

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

February 3, 2000

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 4, 2000

Completed
8.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 21, 2008

Completed
Last Updated

July 2, 2017

Status Verified

April 21, 2008

First QC Date

February 3, 2000

Last Update Submit

June 30, 2017

Conditions

Keywords

ScreeningLongitudinalTransitionTreatmentComorbidityObsessive Compulsive DisorderEvaluationFollow-UpOC Spectrum DisordersOCD

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals must fulfill DSM IV criteria for OCD or OCD-related disorders as determined by a complete psychiatric diagnostic interview (SCID-I, using DSM IV-TR).
  • Individuals must be capable of decision making, and able to comprehend the purpose of the study and to provide informed consent.
  • Individuals can be included if they have certain medical conditions that have been described to have a higher incidence of OCD/depression and anxiety disorders: e.g., individuals with underlying neurological or neuropsychiatric conditions (e.g., tic disorders or dystonias, including torticollis and blepharospasm), connective tissue disorders, but must show no other serious or acute medical illnesses as determined by a physical exam and standard laboratory examinations.
  • Individuals must be at least 18 years old.

You may not qualify if:

  • Alcohol or substance use or dependence of sufficient magnitude to require independent, concurrent treatment intervention (e.g., antabuse or opiate treatment, but not including self-help groups).
  • Current history of aggressive behavior or current suicidal ideation with plan and intent.
  • Current active psychosis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, Maryland, 20892, United States

Location

Related Publications (1)

  • Wiggs CL, Martin A, Altemus M, Murphy DL. Hypervigilance in patients with obsessive-compulsive disorder. Anxiety. 1996;2(3):123-9. doi: 10.1002/(SICI)1522-7154(1996)2:33.0.CO;2-Q.

    PMID: 9160613BACKGROUND

MeSH Terms

Conditions

Anorexia NervosaObsessive-Compulsive DisorderTourette SyndromeTrichotillomania

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental DisordersAnxiety DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTic DisordersMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurodevelopmental DisordersDisruptive, Impulse Control, and Conduct Disorders

Study Design

Study Type
observational
Sponsor Type
NIH

Study Record Dates

First Submitted

February 3, 2000

First Posted

February 4, 2000

Study Start

January 28, 2000

Study Completion

April 21, 2008

Last Updated

July 2, 2017

Record last verified: 2008-04-21

Locations